Expertise in
11
conditions

Jorg Kempfert

Deutsches Herzzentrum Der Charité
Berlin, BE, DE 
Expertise in
11
conditions
Deutsches Herzzentrum Der Charité
Berlin, BE, DE 

Overview

Jorg Kempfert practices practicing medicine in Berlin, Germany.

Kempfert is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Aortic Valve Stenosis, Aortic Regurgitation, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

They are actively involved in clinical research, co-authoring 297 peer reviewed articles and participating in 7 clinical trials.

Locations

Deutsches Herzzentrum der Charité
Berlin, BE, Germany
Other Locations
Hamburg, HH, Germany
Germany
Bad Nauheim, HE, Germany
Leipzig, SN, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
Enrollment Status: Active_not_recruiting
Publish Date: June 02, 2026
Intervention Type: Device
Study Phase: Not Applicable
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne™ PMCF Study)
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation (RESOLVE-MR) (Tendyne™ PMCF Study)
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2026
Intervention Type: Device
Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility, Safety and Performance Trial
Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility, Safety and Performance Trial
Enrollment Status: Completed
Publish Date: August 20, 2024
Intervention Type: Device
Study Phase: Not Applicable
Assessment of the Safety and Performance of the HARPOON™ Beating Heart Mitral Valve Repair System; a Multi-center Post-market Study (ASCEND)
Assessment of the Safety and Performance of the HARPOON™ Beating Heart Mitral Valve Repair System; a Multi-center Post-market Study (ASCEND)
Enrollment Status: Terminated
Publish Date: December 22, 2023
Intervention Type: Device
Study Phase: Not Applicable
Operative Mitralklappenrekonstruktion Bei Funktionellen Mitralklappenvitien Bei Reduzierter Systolischer Ventrikelfunktion
Operative Mitralklappenrekonstruktion Bei Funktionellen Mitralklappenvitien Bei Reduzierter Systolischer Ventrikelfunktion
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Procedure
Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.
Transcatheter Repair of Tricuspid Regurgitation With Cardioband TR System Post-Market Clinical Follow-Up Study (TriBAND): A European Prospective, Multicenter Post-market Clinical Follow-up Study to Assess Transcatheter Tricuspid Valve Repair With Edwards Cardioband TR System in Patients With Symptomatic Chronic Functional Tricuspid Regurgitation.
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2023
Intervention Type: Device
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Enrollment Status: Withdrawn
Publish Date: January 09, 2018
Intervention Type: Device
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

297 Total Publications

Outcomes of Malperfusion Post-Aortic Dissection Repair With the AMDS Hybrid Prosthesis: The DARTS Trial Post Hoc Analysis.
Outcomes of Malperfusion Post-Aortic Dissection Repair With the AMDS Hybrid Prosthesis: The DARTS Trial Post Hoc Analysis.
Journal: JACC. Advances
Published: April 21, 2026

Frequently Asked Questions about Jorg Kempfert

Is Jorg Kempfert a top-rated expert for Transcatheter Aortic Valve Replacement (TAVR)?

MediFind is an objective health platform that identifies experts based on real-world data. Jorg Kempfert is classified as an Elite expert for Transcatheter Aortic Valve Replacement (TAVR), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jorg Kempfert participate in research or clinical trials?

Yes. Jorg Kempfert has published 297 articles and abstracts on conditions like Transcatheter Aortic Valve Replacement (TAVR). You can view a list of Jorg Kempfert's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kempfert's expertise for a condition
ConditionClose
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile